Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Keyword is Clinical Research Division and Keyword is September 2012  [Clear All Filters]
B
Bierle, CJ, Schleiss MR, Geballe AP.  2012.  Antagonism of the protein kinase R pathway by the guinea pig cytomegalovirus US22-family gene gp145.. Virology. 433(1):157-66. Abstract
C
Certo, MT, Gwiazda KS, Kuhar R, Sather B, Curinga G, Mandt T, Brault M, Lambert AR, Baxter SK, Jacoby K et al..  2012.  Coupling endonucleases with DNA end-processing enzymes to drive gene disruption.. Nature methods. 9(10):973-5. Abstract
F
Foss, EJ, Radulovic D, Stirewalt DL, Radich J, Sala-Torra O, Pogosova-Agadjanyan EL, Hengel SM, Loeb KR, Deeg HJ, Meshinchi S et al..  2012.  Proteomic Classification of Acute Leukemias by Alignment-Based Quantitation of LC-MS/MS Data Sets.. Journal of proteome research. 11(10):5005-10. Abstract
G
Graves, SS, Mathes DW, Georges GE, Kuhr CS, Chang J, Butts TM, Storb R.  2012.  Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.. Transplantation. 94(6):562-8. Abstract
H
Hattori, N, Gopal AK, Shields AT, Fisher DR, Gooley T, Pagel JM, Press OW, Rajendran JG.  2012.  131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testes.. Nuclear medicine communications. 33(12):1225-31. Abstract
J
Janes, H, Frahm N, DeCamp A, Rolland M, Gabriel E, Wolfson J, Hertz T, Kallas E, Goepfert P, Friedrich DP et al..  2012.  MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load.. PloS one. 7(8):e43396. Abstract
K
Knaul, FM, Bhadelia A, Gralow J, Arreola-Ornelas H, Langer A, Frenk J.  2012.  Meeting the emerging challenge of breast and cervical cancer in low- and middle-income countries.. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 119 Suppl 1:S85-8. Abstract
Kurland, BF, Gerstner ER, Mountz JM, Schwartz LH, Ryan CW, Graham MM, Buatti JM, Fennessy FM, Eikman EA, Kumar V et al..  2012.  Promise and pitfalls of quantitative imaging in oncology clinical trials.. Magnetic resonance imaging. 30(9):1301-12. Abstract
L
Liu, L, Eisenman RN.  2012.  Regulation of c-Myc Protein Abundance by a Protein Phosphatase 2A-Glycogen Synthase Kinase 3β-Negative Feedback Pathway.. Genes & cancer. 3(1):23-36. Abstract
Lowry, SJ, Loggers ET, Bowles EJA, Wagner EH.  2012.  Evidence gaps in advanced cancer care: community-based clinicians' perspectives and priorities for comparative effectiveness research.. Journal of oncology practice / American Society of Clinical Oncology. 8(3 Suppl):28s-33s. Abstract
M
Maurano, MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, Reynolds AP, Sandstrom R, Qu H, Brody J et al..  2012.  Systematic localization of common disease-associated variation in regulatory DNA.. Science (New York, N.Y.). 337(6099):1190-5. Abstract
McGregor, BA, Syrjala KL, Dolan ED, Langer SL, Redman M.  2012.  The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients.. Brain, behavior, and immunity. Abstract
Mohler, JL, Armstrong AJ, Bahnson RR, Boston B, Busby EJ, D'Amico AV, Eastham JA, Enke CA, Farrington T, Higano CS et al..  2012.  Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(9):1081-1087. Abstract
N
Neph, S, Vierstra J, Stergachis AB, Reynolds AP, Haugen E, Vernot B, Thurman RE, John S, Sandstrom R, Johnson AK et al..  2012.  An expansive human regulatory lexicon encoded in transcription factor footprints.. Nature. 489(7414):83-90. Abstract
P
Pappo, AS, Armstrong GT, Liu W, Srivastava DK, McDonald A, Leisenring WM, Hammond S, Stovall M, Neglia JP, Robison LL.  2012.  Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: A report from the childhood cancer survivor study.. Pediatric blood & cancer. Abstract
R
Radich, JP, Kopecky KJ, Appelbaum FR, Kamel-Reid S, Stock W, Malnassy G, Paietta E, Wadleigh M, Larson RA, Emanuel P et al..  2012.  A randomized trial of dasatinib 100 mg vs imatinib 400 mg in newly diagnosed chronic phase chromic myeloid leukemia.. Blood. Abstract
Rezvani, AR, Storb RF.  2012.  Prevention of graft-vs.-host disease.. Expert opinion on pharmacotherapy. 13(12):1737-50. Abstract
Rogulj, IM, Deeg J, Lee SJ.  2012.  Acute graft versus host disease after orthotopic liver transplantation.. Journal of hematology & oncology. 5:50. Abstract
Roshal, M, Chien S, Othus M, Wood BL, Fang M, Appelbaum FR, Estey EH, Papayannopoulou T, Becker PS.  2012.  The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K.
S
Solh, M, Rai KR, Peterson BL, Kolitz JE, Appelbaum FR, Tallman MS, Belch A, Larson RA, Morrison VA.  2013.  The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).. Leukemia & lymphoma. 54(2):252-254. Abstract
Song, LX, Xu L, Li X, Chang CK, Zhang Y, Wu LY, He Q, Zhang QX, Li X.  2012.  Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.. Annals of hematology. 91(12):1879-1886. Abstract
T
Tangen, CM, Hussain MHA, Higano CS, Eisenberger MA, Small EJ, Wilding G, Donnelly BJ, Schelhammer PF, Crawford DE, Vogelzang NJ et al..  2012.  Improved Overall Survival Trends of Men with Newly Diagnosed M1 Prostate Cancer: A SWOG Phase III Trial Experience (S8494, S8894 and S9346).. The Journal of urology. 188(4):1164-9. Abstract
Tykodi, SS, Satoh S, Deming JD, Chou J, Harrop R, Warren EH.  2012.  CD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft model.. Journal of immunotherapy (Hagerstown, Md. : 1997). 35(7):523-33. Abstract
V
Venner, CP, Wegrzyn Woltosz J, Nevill TJ, Deeg HJ, Caceres G, Platzbecker U, Scott BL, Sokol L, Sung S, List AF et al..  2012.  Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34+ cells from patients with del(5q) myelodysplastic syndrome.. Haematologica. Abstract
Venstrom, JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B et al..  2012.  HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.. The New England journal of medicine. 367(9):805-16. Abstract